Bacterial Therapy of Cancer

Robert M. Hoffman, Ph.D.Professor of Surgery, University of California, San DiegoPresident, AntiCancer, Inc.7917 Ostrow StreetSan Diego, CA 92111USATEL: 1-858-654-2555FAX: 1-858-268-4175Email: all@anticancer.com

• Tumor Targeting Salmonella Typhimurium A1-R: An Overview.- Enhancement of Tumor-Targeted Delivery ofBacteria with Nitroglycerin Involving Augmentation of the ERP Effect.- Oral Delivery of Tumor-Targeting Salmonella to Treat Cancer in Mice.- Microfluidic Device to Quantify the Behavior ofTherapeutic Bacteria in Three-Dimensional Tumor Tissue.- Tumor-Targeting Therapy Using Gene-EngineeredAnaerobic-Nonpathogenic BifidobacteriumLongum.- Noninvasive InVivo Imaging to Follow Bacteria Engaged in Cancer Therapy.- In VivoBioluminescence Imaging of Intra-Tumoral Bacteria.- Employment of Salmonella in Cancer Gene Therapy.- Development of a Targeted Gene Delivery SystemUsing Escherichia Coli.- Isolation and Analysis of Suppressor Mutationsin Tumor-Targeted msbB Salmonella.- Determination of Plasmid Segregational Stabilityin a Growing Bacterial Population.- Visualization of Anti-Cancer Salmonella Typhimurium Engineered forRemote-Control of Therapeutic Proteins.- Methods for Tumor Targeting with Salmonella Typhimurium A1-R.- SalmonellaTyphimurium A1-R and Cell-Cycle Decoy Therapy of Cancer.- Future of Bacterial Therapy of Cancer.